A More Precise Way Of Administering Insulin

Physiologic Insulin Resensitization (PIR) is a physician-directed treatment aimed to simulate how a healthy pancreas releases insulin by administering IV insulin via an FDA-approved insulin pump in rhythmic time-based intervals. It’s used to improve the utilization of insulin and sensitivity at the receptor site. It's especially great for those with Type 1 and 2 diabetes, and those battling chronic kidney disease. Imagine how improving glucose metabolism can improve perfusion in those with insulin resistance for better health, tissue perfusion, wound healing, and even brain function. PIR is a novel approach to administering insulin compared to the traditional way, because of the precision of the infusion improving normal cellular communication. For over a decade, Well Cell has been working to perfect the protocols, having completed approximately 400,000 documented procedures with a strong safety record. They are working alongside the FDA for a potential breakthrough status to offer more confidence to the providers and nurses during treatment with AI predictive analytics.

I am very excited to be a part of bringing PIR into critical access hospitals and in those facilities, it has been empowering to see firsthand some of the patients' responses. This is especially so when they have been struggling with their health and quality of life. I encourage patients to speak with their providers or inquire about PIR to see if it's a treatment that's right for them.

-Jonna Marion, APRN, MSN, FNP-C

We are supporting Yoakum County Hospital in Denver City as they are the FIRST in West Texas to provide this innovate technology! If you are a patient of ours or have questions and want to see if you are a candidate, we can help direct you to their new outpatient clinic service.

What Exactly Is Happening?

Through the use of Physician-Directed Physiologic Insulin Resensitization® (PIR), the physician can administer insulin more precisely, as a hormone rather than a drug. Using insulin in a manner that bio-mimics normal physiology, PIR® is designed to help physicians to reduce their patients’ insulin resistance, which may help blood sugar more readily enter each cell and be converted into energy.

Information on this page is supportive of my collaboration with Well Cell Global and Triad Global Health Solutions. I value this treatment and the positive growth of its implementation into critical access hospitals such as the one in our community. If you are a critical access hospital and would like to know how to bring PIR® into your facility, please let me share with you how to help your patients as well!